| | | | |

Tumor Volume Helps Predict Mesothelioma Survival

13115356_surgeon smallThe size of a mesothelioma tumor in terms of volume appears to have a direct impact on survival, according to cancer researchers at the University of Chicago.

While it may seem obvious that larger mesothelioma tumors result in shorter survival times, tumor volume is not typically used to determine mesothelioma prognosis.

In an article in the Journal of Cardiothoracic Surgery, the research team argues that it should be.

Determining Mesothelioma Prognosis

Clinicians typically use a classification system known as TNM to determine cancer stage and predict mesothelioma survival.

TNM takes into account the size of the mesothelioma tumor (T) and whether it has spread to surrounding tissues, whether lymph nodes in the region are involved (N), and whether mesothelioma cells have spread or metastasized to other parts of the body (M). 

Evaluating Mesothelioma Surgery Patients

But the University of Chicago team says mesothelioma tumor volume may be just as important in predicting survival as the T or N portions of the current staging system.

They evaluated the cases of 111 mesothelioma patients who underwent a lung sparing surgery called extended pleurectomy and decortication (EPD).

After surgery, the team assessed mesothelioma outcomes based on age, gender, histology, tumor volume, and T and N stage..

A Better Way to Predict Mesothelioma Survival?

The research team used a water displacement method to determine the volume of each mesothelioma tumor that was removed during surgery.

The median tumor volume among the 91 men and 20 women was 560 ml, with the largest percentage of mesothelioma patients falling in the 301 to 600 ml range.

The team found that, while tumor volume was directly related to T stage, there was no relationship between the volume of a mesothelioma tumor and N stage (lymph node involvement).

“Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma undergoing EPD…and is complimentary to TNM staging,” concludes Diana Kircheva, whose name appears first on the paper.

An estimated 2,500 Americans receive a mesothelioma diagnosis each year.

Source:

Kircheva, D, et al, Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma, December 18, 2015, Journal of Cardiothoracic Surgery, Epub ahead of print

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…